MorphoSys' vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Investor Contact

Dr. Julia Neugebauer

Senior Director Investor Relations

Phone: +49 89 89927 179

Email Contact

Myles Clouston

Senior Director, Head of US Investor Relations

Phone: +1 857 772 0240

Email Contact

Media Contact

Thomas Biegi

Vice President, Head of Corporate Communications

Phone: +49 89 89927 26079

Email Contact

Sophie Petersen

Senior Specialist Corporate Communications

Phone: +49 89 89927 26033

Fax: +49 89 89927 526033

Email Contact

Jeanette Bressi

Director, US Communications

Phone: +1 617 404 7816

Email Contact